UNICEF s Quality Assurance System for procurement of medicines



Similar documents
Speeding up access to markets: WHO Expert Review Panel & WHO accelerated registration procedure How manufacturers, procurers and patients benefit

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES

Annex 7 Guidelines on pre-approval inspections

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide-memoire for inspection

Guidance for Industry: Starting Material Supplier Management

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

PROCEDURE FOR HANDLING RAPID ALERTS AND RECALLS ARISING FROM QUALITY DEFECTS

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

Pharmaceutical Wholesaler Site Inspection Checklist

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

Working with ICH Quality Guidelines - the Canadian Perspective

Annex 10 Procedure for prequalification of pharmaceutical products

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

MEDICINES CONTROL COUNCIL

gsop Vendor Assessment SOP page 1 of 10

Annex 3 Procedure for prequalification of pharmaceutical products

Annex 9 Guide to good storage practices for pharmaceuticals 1

This guide describes the core components of a SMF suitable for a company holding an importer s or wholesaler s licence.

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

The Quality System for Drugs in Germany

World Health Organization Prequalification of Medicines

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

Recent Updates on European Requirements and what QPs are expected to do

Quality Information. Buchs Manufacturing Site

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

Draft guidance for registered pharmacies preparing unlicensed medicines

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

Iamey/AbWEST AFRICAN HEATH ORGANIZATION PROCEDURE GUIDELINE FOR THE MANAGEMENT OF THE REGIONAL ANTIRETROVIRAL DRUGS BUFFER STOCK

Clinical Trial Logistics

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Annex 4 Good Manufacturing Practices for pharmaceutical products: main principles

Workshop B Control Strategy

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Nevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

20-21 May 2015, Lisbon, Portugal. Highlights. Speakers:

Annex 6. Guidance on variations to a prequalified product dossier. Preface

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

Audit Report in the framework of the APIC Audit Programme

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

What is the correct title of this publication? What is the current status of understanding and implementation?

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Library Guide: Pharmaceutical GMPs

Supplier Quality Assurance

Comparison of EU GMP guidelines with WHO guidelines Identification of the cost-intensive requirements

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

Work plan for GMP/GDP Inspectors Working Group for 2016

The FDA recently announced a significant

Overview of Pre-Approval Inspections

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

GMP Pharma BV. Netherlands

I N T E R A G E N C Y G U I D E L I N E S. a model quality assurance system for procurement agencies

Industry Implications of Pharmaceutical Quality ICH Guidelines

ICH guideline Q10 on pharmaceutical quality system

WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

Quality assurance of pharmaceuticals

QA for LN Procurement by UNICEF Supply Division

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

Author General Management Quality Assurance

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

BRC Food Safety and Quality Management System. New Issue 7

Version 1.0 November 2013 Developed by: Working group of the HPAI Aseptic Services Special Interest Group (ASSIG)

PHARMACEUTICAL QUALITY SYSTEM Q10

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.

Community Guide to Good Practice For Feed Additive and Premixture Operators

Guidance for Industry

Quality Risk Management

Guidance on Qualification of existing facilities, systems, equipment and utilities

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

[NAME OF NATIONAL REGULATORY AUTHORITY] PROCEDURE FOR SUBMISSION CLINICAL TRIAL APPLICATIONS VACCINES AND BIOLOGICALS [COUNTRY]

OVERVIEW OF THE PREQUALIFICATION OF DIAGNOSTICS ASSESSMENT PROCESS. Prequalification of Diagnostics

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV

QUALITY MANAGEMENT SYSTEM

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

Canadian Pharmaceutical GMP

MeriCal Quality Profile

Auditing as a Component of a Pharmaceutical Quality System

GUIDANCE NOTE Building Control (Amendment) Regulations 2014 Procurement Implications for Contracting Authorities

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

INSPECTORS CHECKLIST MONITORING AND INSPECTION VISITS

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan

GMP/Regulatory Environment in the

Staying Current in Cold Chain Management

Presented by Rosemarie Bell 24 April 2014

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, Oct 2009

Transcription:

UNICEF s Quality Assurance System for procurement of medicines QA Specialist Peter Svarrer Jakobsen Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen 23 September 2014

UNICEF QA SYSTEM BASED ON: WRITTEN DOCUMENTATION SYSTEM BASED ON QUALITY MANUAL, DIVISION PROCEDURES AND CENTRE PROCEDURES PRINCIPLES OF THE WHO MODEL QA SYSTEM FOR PROCUREMENT AGENCIES FOLLOWED - TRS 986 ANNEX 3 PRINCIPLES OF PIC-S QUALITY SYSTEM REQUIREMENTS FOR GMP INSPECTORATES FOLLOWED ALL PROCUREMENT ACTIVITIES ARE CENTRALIZED IN UNICEF SUPPLY DIVISION (PROCUREMENT BY UNICEF COUNTRY OFFICES REQUIRES SPECIFIC AUTHORIZATION)

PRE-QUALIFICATION - MEDICINES PRODUCTS PRODUCT QUESTIONNAIRE AS IN THE WHO MODEL QA SYSTEM WHO TRS 986 SUPPLIERS REVIEW OF SUBMITTED DOCUMENTATION AND/OR GOOD MANUFACTURING PRACTICE (GMP) INSPECTIONS TO ENSURE COMPLIANCE WITH WHO GMP GUIDELINES

PRE-QUALIFICATION OF SUPPLIERS HOW? TECHNICAL QUESTIONNAIRE MANUFACTURING SITE (S) DEFINED DOSAGE FORMS / PRODUCTS OF INTEREST EXPORT EXPERIENCE LICENSE TO MANUFACTURE MEDICINAL PRODUCTS IS A GMP INSPECTION NEEDED?

GMP INSPECTIONS DECISION BASED ON THE REGULATORY ENVIRONMENT IN COUNTRY OF ORIGIN AND PRIOR EXPERIENCE OF UNICEF GMP INSPECTION BY UNICEF OR A REPRESENTATIVE SELECTED BY UNICEF CONTRACT MANUFACTURE ONLY ACCEPTED IF SUB- CONTRACTOR ALSO IS APPROVED BY UNICEF

GMP INSPECTIONS BY UNICEF TO CHECK COMPLIANCE WITH WHO GMP GUIDELINES 135 GMP INSPECTIONS CARRIED OUT IN 2007-2014. 24 COMPANIES FAILED (15%) DETAILED GMP INSPECTION REPORT FORWARDED TO COMPANY WITH REQUEST TO RESPOND WITHIN 1 MONTH ANNUAL INSPECTION PLAN IS ESTABLISHED (FREQUENCY OFTEN 2 5 YEARS)

GMP INSPECTIONS COLLABORATION LOCAL AUTHORITY INVITED TO PARTICIPATE JOINT INSPECTIONS WITH WHO PQ, ICRC, MSF UNICEF RELY ON WHO PQ OF VACCINES, HIV, MALARIA AND TB PRODUCTS UNICEF IS A PARTNER TO THE PHARMACEUTICAL INSPECTION COOPERATION SCHEME (PIC-S) UNICEF USE AVAILABLE INFORMATION FROM PARTNERS AND PIC/S MEMBER AUTHORITIES TO WAIVE UNICEF GMP INSPECTIONS COMPANIES THAT ARE FOUND GMP NON-COMPLIANT BY UNICEF PARTNERS SHOULD NOT CONTINUE TO SUPPLY TO UNICEF. INSTANT NOTIFICATION MUST BE PROVIDED

UNICEF SUPPLY DIVISION WAREHOUSE LICENSED BY THE DANISH HEALTH AND MEDICINES AGENCY: TO WHOLESALE OF MEDICINES HANDLE NARCOTIC AND PSYCHOTROPIC SUBSTANCES COMPLIANCE WITH EUROPEAN UNION GUIDELINE ON GOOD DISTRIBUTION PRACTICE (GDP) UNICEF WHOLESALE MEDICINES IT IS NOT SUPPLY UNDER A CONTRACT MANUFACTURE AGREEMENT

PROBLEMS AT UNICEF GOODS RECEIPT NO PACKING LIST MISSING CERTIFICATE AT GOODS RECEIPT PLEASE NOTE: UPON SHIPMENT OF THE ORDER, THE PACKING LIST AND THE RELEVANT CERTIFICATES OF ANALYSIS SHOULD BE SENT AS SEPARATE PDF FILES VIA E-MAIL TO danpackinglists@unicef.org THE ATTACHED FILES SHOULD NOT EXCEED 6MB UNICEF'S PURCHASE ORDER NUMBER SHOULD BE STATED ON THE SUBJECT LINE OF ALL CORRESPONDENCE. FAILURE TO COMPLY WITH THIS PROCEDURE MAY RESULT IN PAYMENT DELAYS.

PROBLEMS AT UNICEF GOODS RECEIPT SUB-HEADER ARIAL 18 LOOSE LABELS ON PRIMARY PACKS (TABLET CONTAINERS) NO LEAFLET OR LEAFLET NOT PACKED TOGETHER WITH THE PRIMARY PACK CERTIFICATE OF ANALYSIS DO NOT INCLUDE NAME OF MANUFACTURING SITE TO LITTLE REMAINING SHELF LIFE (OBTAIN PRIOR APPROVAL IF NEEDED FROM STAFF WHO PLACED THE ORDER)

UNICEF QUALITY CONTROL TESTING ANALYSIS PERFORMED ACCORDING TO AN ANNUAL PLAN BOTH WAREHOUSE SHIPMENTS AND DIRECT SHIPMENTS ARE INCLUDED EXTERNAL LABORATORIES USED FOR THE ANALYSIS (MOST ARE WHO PRE-QUALIFIED) FEW PROBLEMS OBSERVED (MAINLY MARGINALLY LOW ASSAY OR IMPURITIES)

TEMPERATURE CONTROL DURING SHIPMENT GDP REQUIREMENT THAT NEEDS TO BE IMPLEMENTED ALL MANUFACTURERS/SUPPLIERS WILL IN THE FUTURE BE REQUESTED TO DOCUMENT CORRECT SHIPMENT CONDITIONS AT SUPPLY TO SUPPLY DIVISION TEMPERATURES DURING DIRECT SHIPMENTS WILL ALSO NEED TO BE MONITORED

GMP DEFICIENCIES FROM UNICEF INSPECTIONS QUALITY MANAGEMENT QUALITY RISK MANAGEMENT NOT IMPLEMENTED HANDLING OF CHANGES AND DEVIATION ARE POOR ORGANISATION AND PERSONNEL TRAINING IN PRODUCT RELEASE POORLY DOCUMENTED TRAINING IN ASEPTIC PROCEDURES PRODUCTION CLOTHES SHOULD NOT BE WORN OUTSIDE CONTROLLED AREAS

GMP DEFICIENCIES FROM UNICEF INSPECTIONS FACILITIES POOR SEPARATION BETWEEN CONTROL AND NON- CONTROLLED AREAS POOR CONSTRUCTION MATERIALS (DIFFICULT TO MAINTAIN) TOILETS IN PRODUCTION AREAS POOR FLOW OF PERSONNEL FLOW, WHICH PREVENT HANDWASH AT ENTRY TO PRODUCTION AREAS RISK OF CROSS-CONTAMINATION BETWEEN PENICILLINS AND CEPHALOSPORINS DOUBLE STANDARD FACILITIES FOR LOCAL / EXPORT MARKET GENERALLY NOT ACCEPTABLE

GMP DEFICIENCIES FROM UNICEF INSPECTIONS EQUIPMENT HVAC NOT DESIGNED TO ENSURE A GOOD AIRFLOW IN THE AREA. AIRFLOW PATTERNS NOT KNOWN. RE-CIRCULATION OF AIR IN NON-STERILE DUSTY AREAS WITHOUT HEPA FILTRATION BOTH IN GENERAL VENTILATION AND IN SPECIFIC EQUIPMENT E.G. FLUID BED DRYERS RISK OF CROSS-CONTAMINATION DUE TO WRONG AIRFLOW DIRECTION PRODUCTION MANUFACTURING PROCESS NOT VALIDATED OR NOT FOR ALL BATCH SIZES

GMP DEFICIENCIES FROM UNICEF INSPECTIONS DIFFERENT API SOURCE, THAN THE ONE APPROVED BY UNICEF CONTROL OF API SOURCES AND VENDOR QUALIFICATION IS POOR API SOURCE NOT GMP COMPLIANT HANDLING OF ANALYTICAL WORKING STANDARDS NO FORMAL STABILITY REPORT FOR EACH PRODUCT ANNUAL PRODUCT REVIEW NOT TIMELY CARRIED OUT

UNICEF VACCINES Thank you!